about
Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan.Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation.Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysisHepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) studyNatural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY.Transplantation of porcine hepatocytes cultured with polylactic Acid-o-carboxymethylated chitosan nanoparticles promotes liver regeneration in acute liver failure ratsEmployment of digital gene expression profiling to identify potential pathogenic and therapeutic targets of fulminant hepatic failure.The power of the liver transplant waiting list: a case presentation.Metabolic syndrome after a liver transplantation in an Asian population.Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation.Impairment of liver regeneration by the histone deacetylase inhibitor valproic acid in miceExpression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinomaLow expression of GNAI3 predicts poor prognosis in patients with HCC.Living-donor liver transplantation and hepatitis CA proposal to grade the severity of early allograft dysfunction after liver transplantationSerial changes of serum growth factor levels and liver regeneration after partial hepatectomy in healthy humansLong-term quality of life of liver transplant recipients beyond 60 years of age.Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach.De novo cancers following liver transplantation: a single center experience in China.Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials.Fetal liver cell transplantation as a potential alternative to whole liver transplantation?Novel reconstruction of the extrahepatic biliary tree with a biosynthetic absorbable graftThe HALOS-ND model: a step in the journey of predicting hospital length of stay after liver transplantation.Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.Direct acting antiviral agents-based regimen for HCV recurrence after combined liver-kidney transplantation: results from the ANRS CO23 CUPILT study.Early Acute Severe HCV Recurrence After Transplantation: From Universal Mortality to Cure.Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation.New-onset diabetes after liver transplantation and its impact on complications and patient survival.Hepatocyte Transplantation: Cell Sheet Technology for Liver Cell Transplantation.Smad7-overexpressing rat BMSCs inhibit the fibrosis of hepatic stellate cells by regulating the TGF-β1/Smad signaling pathway.Liver transplantation: Toward a unified allocation system.Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.Recipient IL-6-572C/G genotype is associated with reduced incidence of acute rejection following liver transplantation.Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome.The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations.Nitric oxide is critical for avoiding hepatic lipid overloading via IL-6 induction during liver regeneration after partial hepatectomy in mice.Human mesenchymal stromal cell lysates as a novel strategy to recover liver function.
P2860
Q30456435-BDF18F98-DD89-4592-BF57-AE5CE244265FQ33595456-7E958C19-4505-4E85-8631-FEF7E709C2A1Q33719955-86F0E25E-59F6-4B8B-9743-BE5B10860576Q33721402-80280408-BB9F-4031-8D48-F35AAED40104Q34072855-A2F423D9-B169-419E-8503-C1CA662B8349Q34093754-83F90691-2D50-469A-A73E-A456A9ECA5EAQ34680490-7F88DA83-FEFE-4AB6-A494-A231A0926832Q34983757-D2FD8CFD-D9A8-4921-B130-D912107DDBFDQ35033350-1D9A2226-2ECC-4DD4-9703-593B4F4E03BFQ35227416-6D9B6457-4F48-41F2-BC76-D2398F4A2084Q35924990-35533F42-DA33-4CE4-B23D-6F2EF456C3DBQ36051534-EB59869D-E79C-4EE2-BE9C-5BB8943DF54CQ36219935-722C288A-F82C-480B-9011-6FB90B7BE854Q36322057-C6DADD1C-157B-4DBA-B0BC-93ACE26673C6Q36493158-66887AAE-1BE1-4F4D-B948-75D7E4A1ED4DQ36587253-B650F423-1459-4E86-8434-982185A30B32Q36916992-70F9E502-2E2F-42CE-BE1E-53FA6F0BFF5BQ37291375-86A6F2E5-1DAB-44AF-AA3A-A32DCC6A2504Q37300605-6D9BCECC-630B-46C4-9B04-6FA1F6C35806Q37323506-2A92FEC4-37B6-498A-A566-F83271E28137Q37514160-7618076C-F0BB-4024-958A-C4F7C795C591Q37605363-7A6B7067-BA03-43C3-84D7-E9345ED5EE6BQ37709229-450504BA-58BB-4827-841F-CE6A2CA13417Q37893517-1AE858CC-064B-45E3-A5EA-659B4DC6EB5AQ38268224-969D6300-F8E8-4D73-8F42-3F2EEFC42BD3Q38565039-A4E78861-BB96-482C-9F87-0A237A6D6931Q38909070-B11AEBE3-712A-4EAA-ACF4-597BB84B31E6Q40051223-4EF90C71-6E10-4E62-B099-1DE681441D37Q40271222-7720A0F3-C276-474F-8EC1-EFC5CC8621E9Q40635393-52710879-2B3D-4B42-A3D0-7B1842FC5316Q41486937-E0C59591-1D99-4F30-A0C0-51EB4301F8ECQ41564038-8CF63312-9B0F-4F83-9EC4-52428C81DF4DQ41671983-12F356F8-E68A-471D-B506-4D2279D000E4Q43514215-685B9549-3C03-4A68-9F7A-7EE1446303FFQ43955396-2C6BE6B7-45B5-4718-8B04-270226B6E200Q44071446-EE59A5F0-DEBF-4992-9D2E-36F41EFE430AQ44084324-937B2AAD-4413-4A40-AF3A-4333E19D8215Q46851869-5F26A877-2396-48A0-814C-6A4BEEF493D0Q47136208-CE58314D-02A5-4AF7-A67B-F7A63DDC2CF7Q51020056-C31ABEF6-F4D4-439D-8E94-EB372DB87C67
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current status and future of liver transplantation.
@en
Current status and future of liver transplantation.
@nl
type
label
Current status and future of liver transplantation.
@en
Current status and future of liver transplantation.
@nl
prefLabel
Current status and future of liver transplantation.
@en
Current status and future of liver transplantation.
@nl
P356
P1476
Current status and future of liver transplantation.
@en
P2093
Robert M Merion
P304
P356
10.1055/S-0030-1267541
P577
2010-10-19T00:00:00Z